CIRM Bridges students 2022. The CIRM Board approved funding for a program to help even more students advance a career in science. The governing Board of the California Institute for Regenerative Medicine (CIRM) has approved $46,076,430 to invest in its newest education pillar- the COMPASS (Creating Opportunities through Mentorship and Partnership Across Stem cell Science) … Continue reading Stem Cell Agency Invests $46 Million in New Education Program
UC Davis
Life lessons learned in the CIRM summer intern program
SPARK poster session; Photo by Esteban Cortez When I was in high school I spent my summers working in a shoe shop and playing soccer with my mates. It never occurred to me that I could do something really worthwhile with that time. So, when I meet the high school students who took part in … Continue reading Life lessons learned in the CIRM summer intern program
Celebrating academic success and overcoming obstacles
Congratulations to Yasmine Arafa (she/hers), a CIRM Bridges Student Intern at UC Davis Institute for Regenerative Cures! She recently graduated from California State University-Sacramento, officially concluding her Master’s degree and Fulbright Association journey. She conducted research with the aim of developing new therapeutic approaches for rare diseases. Yasmine says, "I have finally passed my thesis defense and am … Continue reading Celebrating academic success and overcoming obstacles
Stem Cell Agency Board Invests in 19 Discovery Research Programs Targeting Cancers, Heart Disease and Other Disorders
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Dr. Judy Shizuru, Stanford University While stem cell and gene therapy research has advanced dramatically in recent years, there are still many unknowns and many questions remaining about how best to use these approaches in developing therapies. That’s why the governing Board of the California Institute … Continue reading Stem Cell Agency Board Invests in 19 Discovery Research Programs Targeting Cancers, Heart Disease and Other Disorders
Stem cells explained in different languages
Science is hard. Explaining complex science to non-scientists is SUPER hard. But explaining science to non-native English speakers presents a whole new set of challenges. I would know. I’m a first-generation immigrant whose highly-educated parents arrived in their new home—the United States—a tad too late to become fluent in its native tongue. I’ve also … Continue reading Stem cells explained in different languages
The power of the patient advocate: how a quick visit led to an $11M grant to fund a clinical trial
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Members of NFOSD visiting UC Davis in 2013 At the California Institute for Regenerative Medicine (CIRM) we are fortunate in having enough money to fund the most promising research to be tested in a clinical trial. Those are expensive projects, often costing tens of millions of … Continue reading The power of the patient advocate: how a quick visit led to an $11M grant to fund a clinical trial
Google eases ban on ads for stem cell therapies
What started out as an effort by Google to crack down on predatory stem cell clinics advertising bogus therapies seems to be getting diluted. Now the concern is whether that will make it easier for these clinics to lure unsuspecting patients to pay good money for bad treatments? A little background might help here. For … Continue reading Google eases ban on ads for stem cell therapies
It’s hard to be modest when people keep telling you how good you are
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST I have a confession. Deep down I’m shallow. So when something I am part of is acknowledged as one of the best, I delight in it (my fellow bloggers Katie and Esteban also delight in it, I am just more shameless about letting everyone know.) And … Continue reading It’s hard to be modest when people keep telling you how good you are
Stem cell agency invests in therapy using killer cells to target colorectal, breast and ovarian cancers
While there have been some encouraging advances in treating cancer in recent decades, there are still many cancers that either resist treatment or recur after treatment. Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved investing in a therapy targeting some of these hard-to-treat tumors. BioEclipse Therapeutics Inc. was awarded nearly … Continue reading Stem cell agency invests in therapy using killer cells to target colorectal, breast and ovarian cancers
Making the list of people to follow
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST If you are walking down the street on a dark night, being followed is not necessarily something you want. But if you are online, having someone follow you is almost always a positive thing. And when that person is Dr. Paul Knoepfler it’s most definitely a … Continue reading Making the list of people to follow
The Stem Cellar 